1. New anti-diabetic drug Morus alba L. (Sangzhi) alkaloids (SZ-A) improves diabetic nephropathy through ameliorating inflammation and fibrosis in diabetic rats. Li C, Liu Q, Ji W, Fu Y, Cao H, Huan Y, Lei L, Gao X, Chen L, Feng C, Zhang L, Li P, Liu Y, Liu S*, Shen Z. Front Med (Lausanne).2023.
2. Voglibose Regulates the Secretion of GLP-1 Accompanied by Amelioration of Ileal Inflammatory Damage and Endoplasmic Reticulum Stress in Diabetic KKAy Mice. Fu Y, Ji W, Liu Q, Zhang L, Li C, Huan Y, Lei L, Gao X, Chen L, Feng C, Lei L, Zhai J, Li P, Cao H, Liu S*, Shen Z. Int J Mol Sci. 2022.
3. Morus alba L. (Sangzhi) Alkaloids Promote Insulin Secretion, Restore Diabetic β-Cell Function by Preventing Dedifferentiation and Apoptosis. Lei L, Huan Y, Liu Q, Li C, Cao H, Ji W, Gao X, Fu Y, Li P, Zhang R, Abliz Z, Liu Y, Liu S*, Shen Z. Front Pharmacol. 2022.
4. Morus alba L. (Sangzhi) alkaloids (SZ-A) exert anti-inflammatory effects via regulation of MAPK signaling in macrophages.Cao H, Ji W, Liu Q, Li C, Huan Y, Lei L, Fu Y, Gao X, Liu Y, Liu S*, Shen Z. J Ethnopharmacol. 2021.
5. Ramulus mori (sangzhi) alkaloids (sz-a) ameliorate glucose metabolism accompanied by the modulation of gut microbiota and ileal inflammatory damage in type 2 diabetic kkay mice. Liu Q, Liu S*, Cao H, Ji W, Li C, Huan Y, Lei L, Fu Y, Gao X, Liu Y and Shen Z*. Front. Pharmacol. 2021.
6. Combination of bis (α -furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through downregulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice. Quan Liu, Linyi Li, Lihui Gao, Caina Li, Yi Huan, Lei Lei, Hui Cao, Ling Li, Anli Gao, Shuainan Liu*, Zhufang Shen*. Basic Clin Pharmacol Toxicol. 2021.
7. Discovery of Novel Indole Derivatives as Fructose-1,6-bisphosphatase Inhibitors and X-ray Cocrystal Structures Analysis. Wang X, Zhao R, Ji W, Zhou J, Liu Q, Zhao L, Shen Z, Liu S*, Xu B*. ACS Med Chem Lett. 2021.
8. The Chinese patent medicine, Jin-tang-ning, ameliorates hyperglycemia through improving β cell function in pre-diabetic KKAy mice. Liu SN, Liu Q, Lei L, Sun SJ, Li CN, Huan Y, Hou SC, Shen ZF*. Chin J Nat Med. 2020.
9. Discovery of N-Arylsulfonyl-Indole-2-Carboxamide Derivatives as Potent, Selective, and Orally Bioavailable Fructose-1,6-Bisphosphatase Inhibitors-Design, Synthesis, In Vivo Glucose Lowering Effects, and X-ray Crystal Complex Analysis. Zhou J, Bie J, Wang X, Liu Q, Li R, Chen H, Hu J, Cao H, Ji W, Li Y, Liu S*, Shen Z*, Xu B*. J Med Chem. 2020.
10. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia.Cui A, Fan H, Zhang Y, Zhang Y, Niu D, Liu S, Liu Q, Ma W, Shen Z, Shen L, Liu Y, Zhang H, Xue Y, Cui Y, Wang Q, Xiao X, Fang F, Yang J, Cui Q, Chang Y. J Clin Invest. 2019.
11. Sirtuin 5 overexpression attenuates glucolipotoxicity-induced pancreatic β cells apoptosis and dysfunction. Yue Wang, Quan Liu, Yi Huan, Rongcui Li, Caina Li, Sujuan Sun, Nan Guo, Miaomiao Yang, Shuainan Liu*, Zhufang Shen*. Experimental Cell Research. 2018.
12. Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance. Li P#*, Liu S#, Lu M#, Bandyopadhyay G, Oh D, Imamura T, Johnson AMF, Sears D, Shen Z, Cui B, Kong L, Hou S, Liang X, Iovino S, Watkins SM, Ying W, Osborn O, Wollam J, Brenner M, Olefsky JM*. Cell. 2016.
13. Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and upregulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: Is that a latent disadvantage? Shuainan Liu, Quan Liu, Linyi Li, Yi Huan, Sujuan Sun, Zhufang Shen*. Journal of Translational Medicine. 2011.
14. The application of 2-NBDG as a fluorescent tracer for assessing hepatic glucose production in mice during hyperinsulinemic euglycemic clamp. Shuainan Liu, Quan Liu, Sujuan Sun, Qian Jiang, Jun Peng, Zhufang Shen*. Acta Pharmaceutica Sinica B. 2012.
15. Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase. Jianbo Bie#, Shuainan Liu#, Zhanmei Li, Yongzhao Mu, Bailing Xu*, Zhufang Shen*. Eur J Med Chem. 2015.
16. 桑枝总生物碱片研发历程回顾(二):现代药理学理念诠释中药的药效特点及药理作用机制. 刘率男, 刘泉, 刘玉玲, 金毅群, 谢明智, 申竹芳*.中国糖尿病杂志. 2020.
17. α-葡萄糖苷酶抑制剂桑枝总生物碱的抗糖尿病作用研究.刘率男, 刘泉, 孙素娟, 李彩娜, 环奕, 陈跃腾, 汪仁芸, 夏学军, 刘志华, 刘玉玲, 谢明智, 申竹芳*.药学学报.2019.
18. 磷酸西格列汀改善2型糖尿病KKAy小鼠糖脂代谢及作用机制探讨.刘率男,刘泉,侯少聪,王悦,申竹芳*.中国临床药理学杂志. 2015.
19. 二甲双胍对2型糖尿病KKAy 小鼠胰岛β细胞功能的影响及初步作用机制探讨.刘率男, 刘 泉, 孙素娟, 侯少聪,王悦,申竹芳*. 药学学报. 2014.
20. 木丹颗粒对谷氨酸钠诱导的胰岛素抵抗小鼠胰岛β细胞功能影响的实验研究.刘率男, 孙素娟, 刘泉,侯少聪,申竹芳*. 中国中西医结合杂志. 2014. 34(7):853-858.
21. 代谢综合征MSG 肥胖大鼠胰岛β 细胞功能紊乱机制的初步研究.刘率男,刘泉,申竹芳*. 药学学报. 2008.
22. 糖尿病治疗新靶点糖原合成酶激酶-3抑制剂的研究进展. 刘率男,申竹芳*.药学学报.2007.